Skip to main content
Log in

A common binding mode that may facilitate the design of novel broad-spectrum inhibitors against metallo-β-lactamases

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Multidrug resistance caused by metallo-β-lactamases (MBLs) remains a therapeutic challenge owing to their broad hydrolytic spectrum on β-lactams, and current β-lactamase inhibitors are ineffective against MBL-carrying superbugs. In this study, we discovered a series of potential inhibitors against various MBLs through a hybrid in silico protocol that combines support vector machine, protein–ligand interaction fingerprint (PLIF) analysis, and molecular docking. These compounds were shown to have a common binding mode. PLIF analysis and molecular docking demonstrated that the sulfonyl oxygens and the amide oxygen coordinated to zinc ions in a similar fashion, indicating the importance of such structural characteristics in the design of broad-spectrum inhibitors against MBLs. In addition, the carbon atom connecting the sulfonyl amide and the nitrogen heterocycle played an important role in ligand flexibility, allowing the rotation of the aromatic ring to accommodate the hydrophobic pockets in the binding site of different subclasses of MBLs. These findings may pave the way to the design of novel broad-spectrum inhibitors against MBLs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ambler RP (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B 289:321–331

    Article  CAS  Google Scholar 

  • Chen J, Yu R, Shen B, Xu Y, Liu Y, Zheng H, Yao W (2013) Docking-based 3D-QSAR modeling of the inhibitors of IMP metallo-β-lactamase. Med Chem Res 22:1730–1739

    Article  CAS  Google Scholar 

  • Dimitriadou E, Hornik K, Leisch F, Meyer D, Weingessel AR (2006) e1071: misc functions of the Department of Statistics (e1071), package version 15-16, TU Wien

  • Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frere JM, Metallo-beta-lactamases Working Group (2001) Standard numbering scheme for class B beta-lactamases. Antimicrob Agents Chemother 45:660–663

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Garau G, Garcia-Saez I, Bebrone C, Anne C, Mercuri P, Galleni M, Frere JM, Dideberg O (2004) Update of the standard numbering scheme for class B beta-lactamases. Antimicrob Agents Chemother 48:2347–2349

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748

    Article  CAS  PubMed  Google Scholar 

  • Liu XH, Ma XH, Tan CY, Jiang YY, Go ML, Low BC, Chen YZ (2009) Virtual screening of Abl inhibitors from large compound libraries by support vector machines. J Chem Inf Model 49:2101–2110

    Article  CAS  PubMed  Google Scholar 

  • Ma XH, Wang R, Yang SY, Li ZR, Xue Y, Wei YC, Low BC, Chen YZ (2008) Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds. J Chem Inf Model 48:1227–1237

    Article  CAS  PubMed  Google Scholar 

  • Ma XH, Wang R, Tan CY, Jiang YY, Lu T, Rao HB, Li XY, Go ML, Low BC, Chen YZ (2010) Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines. Mol Pharm 7:1545–1560

    Article  CAS  PubMed  Google Scholar 

  • Oelschlaeger P, Schmid RD, Pleiss J (2003) Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations. Protein Eng 16:341–350

    Article  CAS  PubMed  Google Scholar 

  • Olsen L, Pettersson I, Hemmingsen L, Adolph HW, Jørgensen FS (2004) Docking and scoring of metallo-beta-lactamases inhibitors. J Comput Aided Mol Des 18:287–302

    Article  CAS  PubMed  Google Scholar 

  • Olsen L, Jost S, Adolph HW, Pettersson I, Hemmingsen L, Jørgensen FS (2006) New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design. Bioorg Med Chem 14:2627–2635

    Article  CAS  PubMed  Google Scholar 

  • Rao H, Li Z, Li X, Ma X, Ung C, Li H, Liu X, Chen Y (2010) Identification of small molecule aggregators from large compound libraries by support vector machines. J Comput Chem 31:752–763

    CAS  PubMed  Google Scholar 

  • Shi Z, Ma XH, Qin C, Jia J, Jiang YY, Tan CY, Chen YZ (2012) Combinatorial support vector machines approach for virtual screening of selective multi-target serotonin reuptake inhibitors from large compound libraries. J Mol Graph Model 32:49–66

    Article  CAS  PubMed  Google Scholar 

  • Siemann S, Evanoff DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI (2002) N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-β-lactamase. Antimicrob Agents Chemother 46:2450–2457

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Vapnik VN (1995) The nature of statistical learning theory. Springer, New York

    Book  Google Scholar 

  • Vella P, Hussein WM, Leung EW, Clayton D, Ollis DL, Mitić N, Schenk G, McGeary RP (2011) The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening. Bioorg Med Chem Lett 21:3282–3285

    Article  CAS  PubMed  Google Scholar 

  • Weide T, Saldanha SA, Minond D, Spicer TP, Fotsing JR, Spaargaren M, Frère JM, Bebrone C, Sharpless KB, Hodder PS, Fokin VV (2010) NH-1,2,3-triazole-based inhibitors of the VIM-2 metallo-β-lactamase: synthesis and structure–activity studies. ACS Med Chem Lett 1:150–154

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Widmann M, Pleiss J, Oelschlaeger P (2012) Systematic analysis of metallo-β-lactamases using an automated database. Antimicrob Agents Chemother 56:3481–3491

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yang XG, Lv W, Chen YZ, Xue Y (2009) In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods. J Comput Chem 31:1249–1258

    Google Scholar 

  • Yuan Q, He L, Ke H (2012) A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity. Antimicrob Agents Chemother 56:5157–5163

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhu K, Lu J, Ye F, Jin L, Kong X, Liang Z, Chen Y, Yu K, Jiang H, Li JQ, Luo C (2013) Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactamase-1. Biochem Biophys Res Commun 431:2–7

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Mr. Yun Shi for meticulous revisions and helpful discussions. This work has been supported by the Qing Lan Projects, Jiangsu 333 High-Level Talents Cultivating Program, the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020304), and the National Natural Science Fund (No. 81102899).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Heng Zheng or Wenbing Yao.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 826 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Liu, Y., Cheng, T. et al. A common binding mode that may facilitate the design of novel broad-spectrum inhibitors against metallo-β-lactamases. Med Chem Res 23, 300–309 (2014). https://doi.org/10.1007/s00044-013-0646-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-013-0646-9

Keywords

Navigation